Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma
Authors
Derek Richard Johnson (ORCID: https://orcid.org/0000-0002-4217-5517)
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma
Derek Richard Johnson, Jann Nagina Sarkaria, Evanthia Galanis, Sani H. Kizilbash et al.
Citations
2 citations
Journal
Neuro-Oncology
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
3.25
article
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma
Derek Richard Johnson, Jann Nagina Sarkaria, Evanthia Galanis, Sani H. Kizilbash, Miroslaw Mazurczak, Elizabeth Yan, S. Keith Anderson, Paul D. Brown, Nadia N. Laack, Jesse G. Dixon, Clinton Leinweber, William G. Breen, Daniel M. Anderson, David Tran, Francois J. Geoffroy
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Neuro-OncologyVol. 27(10)
Institutions
Regions Hospital (US), Sanford Health (US), Mayo Clinic (US), East Carolina University (US), Washington University in St. Louis (US), Alliance for Clinical Trials in Oncology (US), Sanford Research (US), Metro-Minnesota Community Oncology Research Consortium (US), Mayo Clinic in Arizona (US), Alliance Data (United States) (US), Illinois CancerCare (US), Mayo Clinic in Florida (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without dasatinib for glioblastoma — Derek Richard Johnson, Jann Nagina Sarkaria, et al. · Neuro-Oncology (2025) | TGRS Research Map | TGRS